NAT-BENDAMUSTINE
Google image searchProduct monograph
Active ingredient
bendamustine hydrochloride, 25 MG/VIAL
DIN: 02496887
Dosage form(s): POWDER FOR SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Prescription
Company: NATCO PHARMA (CANADA) INC
Date: 25-FEB-2021
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01A — ALKYLATING AGENTS (ATC, ATC/DDD)
- L01AA — Nitrogen mustard analogues (ATC, ATC/DDD)
- L01AA09 — BENDAMUSTINE (ATC/DDD)
Reference brand drug: Treanda
